Enterovirus infections as a possible risk factor for myocardial infarction

Circulation

Volumn 98, Issue 23, 1998, Pages 2534-2537

  Roivainen, Merja ^a   Alfthan, Georg ^a   Jousilahti, Pekka ^a   Kimpimäki, Marko ^a   Hovi, Tapani ^a   Tuomilehto, Jaakko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Follow up studies; Myocardial infarction; Viruses

Indexed keywords

ADULT; ARTICLE; CORONARY RISK; ENTEROVIRUS; FEMALE; FINLAND; GRAM NEGATIVE INFECTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VIRUS DETECTION;

EID: 0032497905     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.23.2534     Document Type: Article

References (27)

1. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
2. Saikku P, Leinonen M, Mattila K, Ekman MR. Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
3. Thorn DH, Grayston JT, Siscowick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infectíon with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268: 68-72.
4. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary heart disease. Lancet. 1996;348: 567-572.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-435.
6. Spodick DH, Flessas AP, Johnsson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol. 1984;53:481-482.
7. Mattila KJ. Viral and bacterial infections in acute myocardial infarction. J Intern Med. 1989;225:293-296.
8. Saikku P, Leinonen M, Tenkanen L, Linnamaki E, Ekman M-R, Manninen V, Mänttäri M, Frick MH, Huttunen J. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273-278.
9. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:1785-90.
10. Hajjar DP, Pomeronz KB, Falcone DJ, Welgler BB, Grant AJ. Herpes simplex virus infection in human arterial cells. J Clin Invest. 1987;80: 1317-1321.
11. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosís. Lancet. 1987; ii:291-293.
12. Melníck JL, Adam E, DeBakey E. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
13. Maze SS, Adolph RJ. Myocarditis: unresolved issues in diagnosis and treatment. Clin Cardiol. 1990;13:69-79.
14. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active coxsackie virus B infection. Am Heart J. 1975:89:283-287.
15. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet. 1977;1:883-884.
16. Nikoskelainen J, Kalliomäki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand. 1983;214:29-32.
17. Grist NR, Bell EJ. A six-year study of coxsackíevinis B infections in heart disease. J Hyg. 1974;73:165-72.
18. Wood SF, Rogen AS, Bell EJ, Grist NR. Role of coxsackie B viruses in myocardial infarction. Br Heart J. 1978;40:523-525.
19. Gríffiths PD, Hannington G, Booth JC, Coxsackie B virus infections and myocardial infarction. Lancet. 1980;1:1387-1389.
20. Roivainen M, Närvänen A, Korkolainen M, Huhtala M-L, Hovi T. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology. 1991;99-107.
21. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus enterovirus. J Clin Microbiol. 1993;31:1083-1087.
22. Puska P, Tuomilehto J, Salonen J, Nissinen A, Virtamo J, Björkqvist S, Koskela K, Neittaanmäki L, Takalo T, Kottke TE, Mäki J, Sipílä P, Varvikko P. The North Karelia Project: Evaluation of a Comprehensive Community Programme for Control of Cardiovascular Diseases in 1972-1977 in North Karelia, Finland. Copenhagen, Denmark: WHO/EURO; 1981.
23. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae infection. Int J Epidemiol. 1994;23:1315-1321.
24. Samuelsson A, Cello J, Skoog E, Glimåker M, Jeansson S, Forsgren M. Enterovirus IgG ELISA using synthetic peptides as antigens. Serodiagnosis and Immunotherapy in Infectious Disease. 1993;5:93-96.
25. Hyöty H. Hiltunen M, Knip M, Laakkonen M, Vähäsalo P. Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Åkerblom HK, and the Childhood Diabetes in Finland Study Group. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes. 1995;44:652-657.
26. Kaufman DL, Erlander MG, Clare-Salzler M. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent mellitus. J Clin Invest. 1992;89:283-292.
27. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27-33.